{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:56:39Z","timestamp":1790733399010,"version":"4.1.0"},"reference-count":76,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R01AR072304"],"award-info":[{"award-number":["R01AR072304"]}]},{"name":"NIH","award":["R01AR043369"],"award-info":[{"award-number":["R01AR043369"]}]},{"name":"NIH","award":["P01CA163222"],"award-info":[{"award-number":["P01CA163222"]}]},{"name":"NIH","award":["R01CA222871"],"award-info":[{"award-number":["R01CA222871"]}]},{"name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","award":["R01AR072304"],"award-info":[{"award-number":["R01AR072304"]}]},{"name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","award":["R01AR043369"],"award-info":[{"award-number":["R01AR043369"]}]},{"name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","award":["P01CA163222"],"award-info":[{"award-number":["P01CA163222"]}]},{"name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","award":["R01CA222871"],"award-info":[{"award-number":["R01CA222871"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>One effort to combat the rising incidence of malignant melanoma is focused on early detection by the clinical and dermoscopic screening of melanocytic nevi. However, the interaction between nevi, which are congenital or acquired benign melanocytic proliferations, and melanoma is still enigmatic. On the one hand, the majority of melanomas are thought to form de novo, as only a third of primary melanomas are associated with a histologically identifiable nevus precursor. On the other hand, an increased number of melanocytic nevi is a strong risk factor for developing melanoma, including melanomas that do not derive from nevi. The formation of nevi is modulated by diverse factors, including pigmentation, genetic risk factors, and environmental sun exposure. While the molecular alterations that occur during the progression of a nevus to melanoma have been well characterized, many unanswered questions remain surrounding the process of nevus to melanoma evolution. In this review, we discuss clinical, histological, molecular, and genetic factors that influence nevus formation and progression to melanoma.<\/jats:p>","DOI":"10.3390\/ijms24043541","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T02:56:13Z","timestamp":1675997773000},"page":"3541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors"],"prefix":"10.3390","volume":"24","author":[{"given":"Rony","family":"Shreberk-Hassidim","sequence":"first","affiliation":[{"name":"Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA"},{"name":"Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA"},{"name":"Department of Dermatology, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA"},{"name":"Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA"},{"name":"Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hoc.2020.08.010","article-title":"Biology of Melanoma","volume":"35","author":"Ostrowski","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000246468","article-title":"What is a nevus? A proposed definition of a common medical term","volume":"191","author":"Happle","year":"1995","journal-title":"Dermatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archderm.139.3.282","article-title":"The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: A population-based estimate","volume":"139","author":"Tsao","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaad.2017.06.149","article-title":"A meta-analysis of nevus-associated melanoma: Prevalence and practical implications","volume":"77","author":"Pampena","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/jdv.18453","article-title":"A review of nevus-associated melanoma: What is the evidence?","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaad.2019.04.043","article-title":"The proportion of nevus-associated invasive melanoma differs with Breslow thickness: A cross-sectional study of 1087 cutaneous melanomas","volume":"81","author":"Folgado","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/DAD.0b013e31815f9854","article-title":"Incidental microscopic foci of nevic aggregates in skin","volume":"30","author":"Dadzie","year":"2008","journal-title":"Am. J. Dermatopathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1365-2133.2009.09073.x","article-title":"Dermoscopic patterns and subclinical melanocytic nests in normal-appearing skin","volume":"160","author":"Scope","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1346-8138.14737","article-title":"Histogenesis of cutaneous malignant melanoma: The vast majority do not develop from melanocytic nevus but arise de novo as melanoma in situ","volume":"46","author":"Saida","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/bjd.20427","article-title":"Melanoma pathology: New approaches and classification","volume":"185","author":"Yeh","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jid.2018.07.045","article-title":"Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations","volume":"139","author":"Dabad","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/bjd.15301","article-title":"Melanoma in congenital melanocytic naevi","volume":"176","author":"Kinsler","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2014.425","article-title":"The genomic landscape of childhood and adolescent melanoma","volume":"135","author":"Lu","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/CMR.0000000000000619","article-title":"Estimated risk of progression of lentigo maligna to lentigo maligna melanoma","volume":"30","author":"Menzies","year":"2020","journal-title":"Melanoma Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaad.2019.03.066","article-title":"Melanoma on chronically sun-damaged skin: Lentigo maligna and desmoplastic melanoma","volume":"81","author":"DeWane","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1309\/AJCP4L5CJGKTJVDD","article-title":"Nevus-associated melanomas: Clinicopathologic features","volume":"142","author":"Shitara","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/archderm.139.12.1620","article-title":"Cutaneous melanomas associated with nevi","volume":"139","author":"Bevona","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2014.09.028","article-title":"Outcome of patients with de novo versus nevus-associated melanoma","volume":"72","author":"Lin","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","article-title":"Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution","volume":"34","author":"Shain","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1038\/onc.2017.189","article-title":"Melanocytic nevi and melanoma: Unraveling a complex relationship","volume":"36","author":"Damsky","year":"2017","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cub.2005.01.031","article-title":"BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma","volume":"15","author":"Patton","year":"2005","journal-title":"Curr. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","article-title":"Braf(V600E) cooperates with Pten loss to induce metastatic melanoma","volume":"41","author":"Dankort","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.20812","article-title":"Risk factors of incident melanocytic nevi: A longitudinal study in a cohort of 1232 young German children","volume":"115","author":"Bauer","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2010.09989.x","article-title":"Activating BRAF mutations in eruptive melanocytic naevi","volume":"163","author":"Sekulic","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/bjd.19819","article-title":"A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences","volume":"185","author":"Dessinioti","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"adv00425","DOI":"10.2340\/00015555-3780","article-title":"Clinicopathological, Genetic and Survival Advantages of Naevus-associated Melanomas: A Cohort Study","volume":"101","author":"Podlipnik","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.jid.2017.12.036","article-title":"Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study","volume":"138","author":"Pandeya","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5694\/mja17.00232","article-title":"Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus","volume":"207","author":"Pan","year":"2017","journal-title":"Med. J. Aust."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"djw121","DOI":"10.1093\/jnci\/djw121","article-title":"De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival","volume":"108","author":"Cymerman","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s12253-020-00858-4","article-title":"De Novo and Nevus-Associated Melanomas: Different Histopathologic Characteristics but Similar Survival Rates","volume":"26","author":"Tas","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2340\/00015555-2908","article-title":"Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1021 Patients","volume":"98","author":"Requena","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00008390-200206000-00011","article-title":"Melanoma with benign melanocytic naevus components: Reappraisal of clinicopathological features and prognosis","volume":"12","author":"Kaddu","year":"2002","journal-title":"Melanoma Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ng.410","article-title":"Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi","volume":"41","author":"Falchi","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjd.20421","article-title":"Melanoma genomics: A state-of-the-art review of practical clinical applications","volume":"185","author":"Guhan","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The Genetic Evolution of Melanoma from Precursor Lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jaad.2014.11.014","article-title":"Histologic features of melanoma associated with CDKN2A genotype","volume":"72","author":"Sargen","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1002\/cncr.10605","article-title":"A natural history of melanomas and dysplastic nevi: An atlas of lesions in melanoma-prone families","volume":"94","author":"Tucker","year":"2002","journal-title":"Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamadermatol.2015.3775","article-title":"Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas","volume":"152","author":"Haenssle","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1038\/s41467-018-06649-5","article-title":"Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways","volume":"9","author":"Duffy","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Akbani","year":"2015","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: From mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"a015388","DOI":"10.1101\/cshperspect.a015388","article-title":"Melanoma: Clinical features and genomic insights","volume":"4","author":"Hawryluk","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.cmr.0000222600.73179.f3","article-title":"BRAF and NRAS mutations in melanoma and melanocytic nevi","volume":"16","author":"Poynter","year":"2006","journal-title":"Melanoma Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2013.429","article-title":"NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi","volume":"134","author":"Charbel","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.3361","article-title":"Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas","volume":"47","author":"Krauthammer","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-13-2625","article-title":"Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence","volume":"74","author":"Nissan","year":"2014","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/pcmr.12422","article-title":"Genetics of melanoma progression: The rise and fall of cell senescence","volume":"29","author":"Bennett","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-12-0052","article-title":"Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma","volume":"18","author":"Menzies","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-437X(99)80004-5","article-title":"The INK4A\/ARF locus and its two gene products","volume":"9","author":"Sharpless","year":"1999","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ccell.2018.05.014","article-title":"Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation","volume":"34","author":"Zeng","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cup.13689","article-title":"Germline mutations predisposing to melanoma","volume":"47","author":"Toussi","year":"2020","journal-title":"J. Cutan. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/hmg\/ddv029","article-title":"Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter","volume":"24","author":"Visser","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/pcmr.12620","article-title":"Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells","volume":"31","author":"Chhabra","year":"2018","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"djw004","DOI":"10.1093\/jnci\/djw004","article-title":"Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways","volume":"108","author":"Gibbs","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1111\/bjd.15784","article-title":"Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: A pooled international study of primary melanomas","volume":"177","author":"Gibbs","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bjd.18881","article-title":"Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival","volume":"183","author":"Ward","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajhg.2010.05.017","article-title":"IRF4 variants have age-specific effects on nevus count and predispose to melanoma","volume":"87","author":"Duffy","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","article-title":"A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma","volume":"480","author":"Yokoyama","year":"2011","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jid.2013.272","article-title":"Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients","volume":"134","author":"Sturm","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/120347549900300603","article-title":"Malignant melanoma arising from nevi, p53, p16, and Bcl-2: Expression in benign versus malignant components","volume":"3","author":"Radhi","year":"1999","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.0022-202X.2004.22243.x","article-title":"Genetic interaction between NRAS and BRAF mutations and PTEN\/MMAC1 inactivation in melanoma","volume":"122","author":"Tsao","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.187252.112","article-title":"Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis","volume":"26","author":"Vredeveld","year":"2012","journal-title":"Genes Dev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0190-9622(03)02473-3","article-title":"PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma","volume":"49","author":"Tsao","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","article-title":"Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color","volume":"117","author":"Kennedy","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ijc.29018","article-title":"MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project","volume":"136","author":"Pasquali","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamadermatol.2016.0524","article-title":"Red Hair, Light Skin, and UV-Independent Risk for Melanoma Development in Humans","volume":"152","author":"Roider","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jamadermatol.2016.0050","article-title":"Human Determinants and the Role of Melanocortin-1 Receptor Variants in Melanoma Risk Independent of UV Radiation Exposure","volume":"152","author":"Wendt","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature11624","article-title":"An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background","volume":"491","author":"Mitra","year":"2012","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/00015550410025903","article-title":"Frequency and distribution pattern of melanocytic naevi in Swedish 8\u20139-year-old children","volume":"84","author":"Synnerstad","year":"2004","journal-title":"Acta Derm. Venereol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:29:39Z","timestamp":1760120979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":76,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24043541"],"URL":"https:\/\/doi.org\/10.3390\/ijms24043541","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}